IE 11 is not supported. For an optimal experience visit our site on another browser.
  • UP NEXT

    Try these dance-inspired workouts designed to boost your mood

    04:18
  • What questions should you ask during your next visit to the doctor?

    05:26
  • How much water is too much water? Doctor weighs in

    04:15
  • How to safely store medicine — and when you should throw it away

    04:32
  • Psychiatrist shares tips for reducing stress: 'Feelings aren't facts'

    04:03
  • How to make sure you're taking common medications correctly

    05:19
  • Weight-loss drugs could see a shortage until 2025, makers predict

    03:38
  • Feeling stuck? How to find or reignite your life’s purpose

    04:40
  • What is 'eldest daughter syndrome'? What birth order reveals

    04:38
  • Why more moms are looking to midwifery for their birth journey

    07:23
  • Get a full-body workout with this routine — no equipment needed!

    03:41
  • With spring come ticks and allergies: How to stay safe and healthy

    04:02
  • Multitasking myths: No, we can’t do several things at once

    03:37
  • See Lenny Kravitz workout in full rockstar attire

    00:49
  • Psychotherapist shares secrets to communicating effectively

    04:10
  • New study shows daily incentives help you reach exercise goals

    06:10
  • What is ‘cozy cardio’ and how effective is it?

    03:29
  • Dermatologist shares tips to help women combat hair loss

    04:39
  • Anti-diet movement aims to brush off shame of obesity

    03:21
  • Dermatologist-approved skincare solutions for the whole family

    03:14

Remdesivir company CEO: It’s ‘not a cure, but a very significant treatment’

08:51

In the wake of a government-sponsored clinical trial that showed promising results for the experimental drug remdesivir to treat coronavirus, Daniel O’Day, chairman and CEO of Gilead Sciences, talks to TODAY in an NBC News exclusive. He says it’s “not a cure, but a very significant treatment” that can “reduce the time it takes patients to get better,” reducing the strain on health care systems. He promises Gilead will work to make the drug “accessible and affordable,” and says they are looking at ways to use the drug for other patients besides the most severely ill.